Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Gemin X's Bcl-2 inhibitors are effective proapoptotic and antitumor compounds

Nov. 28, 2002

Cotara receives orphan drug status in E.U.

Nov. 27, 2002

New series of HDAC inhibitors prepared and tested by Roche researchers

Nov. 27, 2002

Allergan licenses rights to PEP-005 from Peplin Biotech

Nov. 27, 2002

Vertex presents novel inhibitors of caspase and TNF-alpha production

Nov. 27, 2002

PX-478, the lead in a novel class of HIF-1 inhibitors with excellent antitumor activity

Nov. 26, 2002

Antiangiogenic/antimetastatic peptide completes preclinical evaluation

Nov. 26, 2002

Inhibitor of novel cancer target is selectively cytotoxic to tumor cells

Nov. 26, 2002

Bayer claims Raf kinase inhibitors with utility in cancer

Nov. 26, 2002

Novel Src kinase inhibitors in early development at AstraZeneca

Nov. 26, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...